Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

April 23, 2024

Clinical Outcome Assessment — Initial Public Discussion

In this presentation from C-Path's rare and orphan disease program, you will see...

April 22, 2024

Unlocking the Capabilities of Large Language Models for Accelerating Drug Development

Recent breakthroughs in natural language processing (NLP), particularly in large language models (LLMs), offer substantial...

April 17, 2024-April 18, 2024

2024 Clinical Outcome Assessment Program Annual Meeting

On April 17-18, 2024, the 2024 Clinical Outcome Assessment Annual Meeting...

April 17, 2024

C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia

TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E

April 17, 2024

C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward

TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a

April 10, 2024

Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton

Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.

April 1, 2024

C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development

March 28, 2024

C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research

Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...

March 26, 2024

C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency

Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...

March 25, 2024

C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy

Critical Path Institute (C-Path) today announced the formation of a new task force...

Previous3031 32...135 Next